CYP2C9 and colorectal cancer: Consistent evidence supports a role for polymorphisms of the cytochrome P450 CYP2C9 gene that produce decreased enzymatic activity as a protecting factor for colorectal cancer susceptibility (Martinez et al., 2001; Chan et al., 2004, 2009; Cleary et al., 2010; Northwood et al., 2010).